Acute Coronary Artery Thrombosis Associated with Synthetic Cannabinoid Intoxication

Abstract

Synthetic cannabinoids are drugs of abuse that have rapidly gained popularity in the United States primarily due to their easy availability, inconsistent regulation, and lack of detectability on routine drug screens. Numerous case reports of adverse physical and psychological effects occurring in certain users have raised concerns that these drugs may not be as harmless as advertised, nor as similar to their plant-derived cannabis counterpart tetrahydrocannabinol (THC), as users may assume. Presented is a case of a 57-year-old man who died as a result of an acute coronary artery thrombosis immediately after smoking synthetic cannabinoids. Synthetic cannabinoids in this case were confirmed on directed postmortem toxicology testing, despite the routine postmortem drug screen being negative. Adverse cardiovascular side effects in association with these substances have only been reported in a few individuals; however, public education of the possibility for serious outcomes is needed. Medical examiners should be made aware of the potential toxicity of these drugs and the fact that they are only detected through specialized toxicological analysis. Additional research and case reports are necessary to fully understand the chemical composition and subsequent side effect profile of these drugs.

Keywords

Forensic pathology Synthetic cannabinoids Acute coronary thrombosis

Get full access to this article

View all access options for this article.

References

Gurney

S.M.R.

Scott

K.S.

Kacinko

S.L.

Pharmacology, toxicology and adverse effects of synthetic cannabinoid drugs. Forensic Sci Rev. 2014 Jan; 26(1): 53–78.

Logan

B.K.

. Marijuana and the cannabinoids. Totowa (NJ): Humana Press; c2007. Chapter 12, Marijuana and driving impairment; p. 277–94. https://dx-doi-org.web.bisu.edu.cn/10.1007/978-l-59259-947-9_12.

Centers for Disease Control and Prevention (CDC). Notes from the field: Severe illness associated with synthetic cannabinoid use -Brunswick, Georgia, 2013. MMWR Morb Mortal Wkly Rep. 2013 Nov 22 [cited 2014 Aug 16]; 62(46): 939. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6246a7.htm.

Thematic paper - Understanding the “spice” phenomenon [Internet]. Luxembourg: Office for Official Publications of the European Communities. 2009 Nov [cited 2014 Aug 16]. 34 p. Available from: http://www.emcdda.europa.eu/publications/thematic-papers/spice.

Fattore

Fratta

. Beyond THC: the new generation of cannabinoid designer drugs. Front Behav Neurosci. 2011 Sep 21; 5: 60. https://dx-doi-org.web.bisu.edu.cn/10.3389/fnbeh.2011.00060. PMid: 22007163. PMCid: PMC3187647.

Gay

. Synthetic marijuana spurs state bans. New York Times [Internet]. 2010 Jul 11 [cited 2014 Aug 16]: A17. Available from: http://www.nytimes.com/2010/07/11/us/11k2.html?_r=0.

Harris

C.R.

Brown

. Synthetic cannabinoid intoxication: a case series and review. J Emerg Med. 2013 Feb; 44(2): 360–6. https://dx-doi-org.web.bisu.edu.cn/10.1016/j.jemermed.2012.07.061. PMid: 22989695.

Ibrahim

Al-Saffar

Wannenburg

. A unique case of cardiac arrest following K2 abuse. Case Rep Cardiol. 2014; 2014: 120607.

Mir

Obafemi

Young

Kane

. Myocardial infarction associated with use of the synthetic cannabinoid K2. Pediatrics. 2011 Dec; 128(6): e1622–7.

10.

Seely

K.A.

Lapoint

Moran

J.H.

Fattore

. Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids. Prog Neuropsychopharmacol Biol Psychiatry. 2012 Dec 3; 39(2): 234–43. https://dx-doi-org.web.bisu.edu.cn/10.1016/j.pnpbp.2012.04.017. PMid: 22561602. PMCid: PMC3936256.

11.

Shields

Ali

Rubio

Abstract #G71 : Death due to excited delirium associated with synthetic marijuana use: a review of two recent cases. Proc Am Acad Forensic Sci. 2013 Feb; 29: 333–4.

12.

Arntson

Ofsa

Lancaster

Validation of a novel immunoassay for the detection of synthetic cannabinoids and metabolites in urine specimens. J Anal Toxicol. 2013 Jun; 37(5): 284–90. https://dx-doi-org.web.bisu.edu.cn/10.1093/jat/bkt024. PMid: 23625703.

13.

Stoppacher

. Synthetic cannabinoid use and sudden death. Acad Forensic Pathol. 2012 Jun; 2(2): 202–5.

14.

Randall

R.D.

Kendall

D.A.

O'Sullivan

. The complexities of the cardiovascular actions of cannabinoids. Br J Pharmacol. 2004 May; 142(1): 20–6. https://dx-doi-org.web.bisu.edu.cn/10.1038/sj.bjp.0705725. PMid: 15131000. PMCid: PMC1574918.

15.

Lapoint

James

L.P.

Moran

C.L.

Severe toxicity following synthetic cannabinoid ingestion. Clin Toxicol (Phila). 2011 Oct; 49(8): 760–4. https://dx-doi-org.web.bisu.edu.cn/10.3109/15563650.2011.609822. PMid: 21970775. PMCid: PMC4165603.

16.

Young

A.C.

Schwarz

Medina

Cardiotoxicity associated with synthetic cannabinoid K9, with laboratory confirmation. Am J Emerg Med. 2012 Sep; 30(7): 1320.e5–7.

17.

Aryana

Williams

M.A.

. Marijuana as a trigger of cardiovascular events: speculation or scientific certainty? Int J Cardiol. 2007 May 31; 118(2): 141–4 https://dx-doi-org.web.bisu.edu.cn/10.1016/j.ijcard.2006.08.001. PMid: 17005273.